PD-L1 expression and survival in p16-negative and -positive squamous cell carcinomas of the vulva

AIM: Programmed death-ligand 1 (PD-L1) has become a widely used predictive biomarker for therapy with checkpoint inhibitors in a variety of cancers. Here, we studied the expression of PD-L1 in squamous cell carcinomas of the vulva (SCCV) with regard to HPV status via its surrogate marker p16. Additi...

Descripción completa

Detalles Bibliográficos
Autores principales: Czogalla, Bastian, Pham, Deborah, Trillsch, Fabian, Rottmann, Miriam, Gallwas, Julia, Burges, Alexander, Mahner, Sven, Kirchner, Thomas, Jeschke, Udo, Mayr, Doris, Schmoeckel, Elisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Article – Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7040065/
https://www.ncbi.nlm.nih.gov/pubmed/32025868
http://dx.doi.org/10.1007/s00432-020-03126-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7040065/
https://www.ncbi.nlm.nih.gov/pubmed/32025868
http://dx.doi.org/10.1007/s00432-020-03126-9

Ejemplares similares